Keep the air conditioning running while you are driving
The SELECT trial (published in NEJM 2023) established semaglutide's cardiovascular benefits in patients with established cardiovascular disease and overweight or obesity but without diabetes
patients receiving semaglutide in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia
Example 2 Names of laboratory analyses used internally in clinical data warehouses often lack specificity in terms of reagent, test kit or potential supplementary reagents used or required
At 50, I now have a life I had only dreamed of a year before
Additionally, allergic reactions, though uncommon, can occur